1. Home
  2. Flashcards
  3. Preview

Therapeutics - Pain 1

The flashcards below were created by user kyleannkelsey on FreezingBlue Flashcards.

  1. In pain assessment what does PQRST stand for?
    • P: Palliative/Provoking factors (What makes it better or worse)
    • Q: Quality (Describe)
    • R: Radiation (where is it)
    • S: Severity (How is it now compared to previously)
    • T: Temporal (intensity change with time)
  2. Is PQRST objective or subjective?
    Both
  3. Numeric or Wong faces pain scales assess what factor of pain?
    Intensity/Severity
  4. What is a mild pain score on an 11 point scale?
    1-3
  5. What is a Moderate pain score on an 11 point scale?
    4-6
  6. What is a Severe pain score on an 11 point scale?
    7-10
  7. What are the general treatments for Mild pain?
    • Non-opioid:
    • APAP
    • ASA
    • NSAIDs
  8. What are the general treatments for mild-moderate pain?
    • Opioids with or without an adjuvant
    • Codeine
    • Tramadol
  9. What are the general treatments for moderate-severe pain?
    • Opioids with or without an adjuvant
    • Morphine
    • Fentanyl
  10. What are the most common routes of administration for acute pain?
    Parenteral or Oral
  11. What are the most common routes of administration for Chronic pain?
    Oral or Transdermal
  12. What is the Therapeutic goal for acute pain?
    Pain relief
  13. What is the Therapeutic goal for chronic pain?
    Pain prevention
  14. What is the desired duration of pain control for acute pain?
    2-4 hours
  15. What is the desired duration of pain control for chronic pain?
    As long as possible
  16. What is the frequency of pain control dosing for acute pain?
    As needed
  17. What is the frequency of pain control dosing for chronic pain?
    Scheduled
  18. How is the dose generally calculated for acute pain?
    Standard calculations
  19. How is the dose generally calculated for chronic pain?
    Individually titrated
  20. Is adjuvant medication common for acute pain?
    No
  21. Is adjuvant medication common for chronic pain?
    Yes
  22. Does acute pain require rapid OOA?
    Yes
  23. Does chronic pain require rapid OOA?
    No
  24. What is the mainstay for pain management?
    OTC analgesics
  25. What is the pediatric dosing for APAP or IBU?
    • 10 mg/kg
    • (APAP can be 10-15 mg/kg)
    • Q4-6 hours
  26. APAP has what therapeutic properties?
    Antipyretic and analgesic
  27. Does APAP have Anti-inflammatory properties?
    No
  28. APAP is indicated for what severity of pain?
    Mild to moderate
  29. APAP is indicated for moderate to severe pain in what situation?
    In combination
  30. What is the maximum dose of APAP?
    • 4000 mg (3000 mg is become more common)
    • 325 mg in Combination products
  31. What score should you evaluate if a person in on APAP?
    Child Pugh score
  32. What is the brand name for the IV APAP formulation
    Ofirmev
  33. What is the conc. of Ofirmev?
    1000 mg/100 mL APAP
  34. What is the age range for Ofirmev?
    >2 years
  35. What are the indications for Ofirmev (APAP IV)?
    • Mild to moderate pain
    • Moderate to severe pain with adjunctive meds
    • Reduction of fever
  36. How long can you use Ofirmev (APAP IV) after surgery?
    Up to 24 hrs
  37. What are the advantages/benefits of using Ofirmev (APAP IV)?
    • Opioid sparing
    • No 1st pass
    • Safe/tolerable
    • NPO patients
    • Post surgery
  38. What are the cons of Ofirmev (APAP IV)?
    Mask fever
  39. APAP is centrally or peripherally acting?
    Centrally
  40. NSAIDs are centrally or peripherally acting?
    Both
  41. NSAID have antipyretic, analgesic or anti-inflammatory effects?
    All
  42. What are the indications for NSAIDs?
    • Mild to moderate pain, including:
    • Soft tissue injury
    • Sprains
    • Dose sparing with opioids
  43. How long should you use an NSAID to verify that it has failed?
    2 weeks
Author
kyleannkelsey
ID
282528
Card Set
Therapeutics - Pain 1
Description
Therapeutics - Pain 1
Updated
Show Answers

  1. n Home
  2. Flashcards
  3. Preview